Skip to main content
. Author manuscript; available in PMC: 2014 Mar 9.
Published in final edited form as: Oncogene. 2012 Oct 8;32(36):4252–4263. doi: 10.1038/onc.2012.438

Figure 7. The OSIC-like CD49f−CD133+ phenotype identifies a small fraction of transformed cells in patient samples of either primary or metastatic osteosarcoma.

Figure 7

(A) FACS analysis of CD49f−CD133+ versus CD49f+ cells in TTC444 cells. Ab, antibody. (B-D) HE staining of the paired tissue samples from both primary and concordant metastatic pulmonary sites in 3 osteosarcoma patients. Parallel immunohistochemical assay detected the expression of CD49f, CD133, and CXCR4 in these samples.

HHS Vulnerability Disclosure